Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

News
November 4, 2013 — A new study demonstrated that some patients may not need to receive prolonged anti-clotting therapy ...
Home November 04, 2013
Home
tryton stent, bifurcation stenting
Feature
November 1, 2013 — A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare ...
Home November 01, 2013
Home
News

November 1, 2013 – In the first head-to-head randomized controlled trial of third-generation durable-polymer drug ...

Home November 01, 2013
Home
News
November 1, 2013 — A new study showed that a conservative approach to revascularization for patients with intermediate ...
Home November 01, 2013
Home
cath lab drug-eluting balloons stents bare metal clinical trial study RIBS V
Feature
November 1, 2013 — A clinical trial comparing the use of drug-eluting stents (DES) and drug-eluting balloons (DEB) in ...
Home November 01, 2013
Home
bifurcation stenting
Feature
November 1, 2013 — A new clinical trial showed that a two-stent technique for treatment of bifurcation lesions with a ...
Home November 01, 2013
Home
Feature
November 1, 2013 — A study found that both drug-eluting stents (DES) with biocompatible polymers and DES with ...
Home November 01, 2013
Home
stents biforcation clinical trial study cath lab tryton tct side branch
Feature
October 31, 2013 — Tryton Medical Inc., a developer of stents designed to treat bifurcation lesions, announced ...
Home October 31, 2013
Home
News
October 31, 2013 — Abbott announced it plans to initiate a randomized, controlled trial in the United States to evaluate ...
Home October 31, 2013
Home
News
October 31, 2013 — Amaranth Medical presented positive six-month angiographic results from its first-in-human study of ...
Home October 31, 2013
Home
News
October 29, 2013 — OrbusNeich announced the publication of a study demonstrating that lesion preparation with the ...
Home October 29, 2013
Home
News
October 29, 2013 — Biotronik Japan announced enrollment of the first patient in the Bioflow-IV study, which aims to ...
Home October 29, 2013
Home
News
October 28, 2013 — Biosensors International’s expanded product portfolio offers physicians a broader range of treatment ...
Home October 28, 2013
Home
News

October 23, 2013 — Vascular Interventional Advances (VIVA) Physicians, a not-for-profit organization dedicated to ...

Home October 23, 2013
Home
News

October 21, 2013 — Bard Peripheral Vascular has sent an urgent Class I medical device recall notification letter ...

Home October 21, 2013
Home
Subscribe Now